| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.1M | $386.9K | $3.2M |
| YoY Revenue Growth % | +430.7% | -87.8% | — |
| Gross Profit | $83.0K | -$3.5M | — |
| Gross Margin % | 4.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.5M | -$11.0M | -$7.9M |
| Operating Margin % | -71.8% | -80.0% | -80.0% |
| Net Income (GAAP) | -$5.6M | -$30.1M | -$7.4M |
| EBITDA (Normalized) | -$1.3M | -$11.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.7M | -$2.8M | -$5.7M |
| Capital Expenditures (CapEx) | $160.9K | $976 | — |
| Free Cash Flow (FCF) | -$2.8M | -$2.8M | -$5.7M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $443.7K | $146.5K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$22.7M | -$16.5M | — |